TOP2A and hepatocellular carcinoma: Mechanistic studies suggested that cDCBLD2 can bind to miR-345-5p through a ceRNA mechanism, increase the stability of type IIA topoisomerase (TOP2A) mRNA as a miRNA sponge, and reduce the drug killing effect of sorafenib on HCC cells by inhibiting apoptosis.